Marsha Rose Gillentine

Marsha Rose Gillentine, Ph.D., is a director in Sterne Kessler’s Biotechnology & Chemical and Trial & Appellate Practice Groups. 

Marsha is primarily focused on the pharmaceutical industry. 

She is intimately familiar with the Hatch-Waxman Act and Biologics Price Competition and Innovation Act and understands patent litigation strategy in the context of the statutory schemes and Patent Office Litigation. 

Marsha is sought by both innovator and generic pharmaceutical and biopharmaceutical companies for assistance with intellectual property issues related to their pharmaceutical products, including freedom-to-operate analyses and lifecycle management strategies.